StockNow
Log in
U.S. Markets

Citrini says Schrödinger (SDGR) has equity stake in Ajax target, positioned to benefit from Eli Lilly (LLY) deal

StockNow breaking-news AI analysis

Schrödinger's 6% stake in Ajax Therapeutics, recently acquired by Eli Lilly, validates its AI-driven platform and offers financial upside as part of Lilly's aggressive 2026 M&A strategy.

2 stocks

What do investors think?

Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactions

StockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.

Today's market highlights

A selection of stories drawing attention in the market.

See more
Geopolitics

Gulf official tells CNN “50:50” chance US and Iran could reach deal by Friday, CNN reports; Iranian delegation does not include IRGC, which would need to sign off on details of provisional agreement

Geopolitics

The draft agreed to by Iranian and Omani negotiators awaits final approval from Iran’s supreme leader, two regional officials told The Associated Press on Wednesday

Geopolitics

Only 'one or two issues' remain unresolved in Iran-Oman talks, a senior diplomatic source tells Al Jazeera